The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)

This publication has 41 references indexed in Scilit:

• Overview of Current Noninodilator Therapies for Acute Heart Failure Syndromes
  The American Journal of Cardiology, 2005
• Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
  The American Journal of Cardiology, 2005
• Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure
  International Journal of Cardiology, 2005
• Biochemical markers of myocyte injury in heart failure
  Heart, 2004
• Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design
  American Heart Journal, 2004
• Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)
  The American Journal of Cardiology, 2004
• Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis
  American Heart Journal, 2004
• Prognostic Value of Combination of Cardiac Troponin T and B-Type Natriuretic Peptide after Initiation of Treatment in Patients with Chronic Heart Failure
  Clinical Chemistry, 2003
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
  The Lancet, 2002
• Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular Failure
  New England Journal of Medicine, 1982